Clinical trials
Ischemic clinical trials
Below are recruiting ischemic clinical trials, each written for real people, not researchers. We’re tracking 814 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07302971Recruiting
Telemedicine for stroke care in Chinese hospitals
This study tests if connecting smaller hospitals with stroke experts through telemedicine improves treatment for people having an acute ischemic stroke. It may help you get faster, better care if you live in a less populated area.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07291024Recruiting
Vagus nerve stimulation and walking therapy for stroke recovery
This trial tests if pairing vagus nerve stimulation with walking exercises can help people who had a stroke more than six months ago improve their walking speed and mobility.
Rochester, MinnesotaAges 18 years+ - NCT07294209RecruitingPhase 4
Low-dose tenecteplase for older adults with stroke
This trial tests a lower dose of the clot-busting drug tenecteplase in people aged 70 and older who have had an ischemic stroke. It aims to see if this treatment is safe and effective for older patients when given within 4.5 hours of symptoms starting.
Chongqing, Chongqing MunicipalityAges 70 years+ - NCT07290751RecruitingPhase 4
Adding tirofiban to clot-busting for stroke patients
This trial tests whether adding a second medicine (tirofiban) to standard clot-busting treatment can help people who are not improving after the first hour. It is for people with a moderate to severe stroke who are not candidates for a clot-removal procedure.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07290244RecruitingPhase 1
Testing ER-100 safety for glaucoma or NAION patients
This trial tests whether a new drug, ER-100, is safe for people with glaucoma or a sudden optic nerve injury called NAION. It aims to see if the drug can be given without serious side effects.
Glendale, CaliforniaAges 40–85 - NCT06541691Recruiting
Aspirin for heart disease patients in polluted air
This study tests if different types of aspirin (coated or chewable) and a special schedule can help people with heart or blood vessel disease when they are exposed to air pollution. If you live in Tehran and have stable heart disease, you may be able to join.
Tehran, Tehran ProvinceAges 18 years+ - NCT07279493RecruitingPhase 2
Testing KPCXM18 injection for acute ischemic stroke within 12 hours
This trial tests an investigational injection called KPCXM18 for people having an acute ischemic stroke. It is given within 12 hours of symptom onset, in addition to standard clot-dissolving treatment, to see if it improves recovery and safety.
Beijing, Beijing MunicipalityAges 18–80 - NCT07283159RecruitingPhase 2
Tenecteplase plus a second drug for stroke recovery
This study tests whether giving a second drug (urinary kallidinogenase) after the clot-busting drug tenecteplase can help people with moderate to severe ischemic strokes recover better. It is for patients who started treatment within 4.5 hours of symptoms.
ShenyangAges 18 years+ - NCT07279259RecruitingPhase 2
Blood pressure management after stroke clot-dissolving treatment
This trial tests how managing high blood pressure during clot-dissolving treatment for acute ischemic stroke affects recovery. It is for patients who have high blood pressure at the start of treatment.
ShanghaiAges 18–80 - NCT06262529Recruiting
Thinking after a Stroke: A Study of Memory and Thinking
This study looks at thinking and memory problems in younger adults (18 to 45) who have had an ischemic stroke. It aims to understand how a stroke affects the brain's ability to think clearly.
CannesAges 18–45 - NCT07270887Recruiting
Can gentle arm cuffs protect your heart and brain over time?
This trial tests if using a blood pressure cuff on your arm in short cycles can help prevent future heart attacks, strokes, and other problems in people at very high risk. You may qualify if you've already had a major heart or blood vessel event.
ShenyangAges 40 years+ - NCT06604117Recruiting
Probucol and statins for recent ischemic stroke
This trial tests whether adding probucol to statin therapy can help people who recently had an ischemic stroke caused by hardened arteries. The goal is to see if this combination works better than statins alone for preventing future strokes.
Xicheng District, Beijing MunicipalityAges 18 years+ - NCT07264166Enrolling by invitation
Gene therapy trial for cerebral palsy and HIE
This trial tests a gene therapy given as a nose spray for people with cerebral palsy or HIE. It aims to see if the treatment is safe and helps improve movement over two years.
Monterrey, Nuevo LeónAges 2–65 - NCT07241520RecruitingPhase 3
Testing SHPL-49 injection for recent stroke patients
This trial tests a new medication, SHPL-49, given as an injection to people who have just had a stroke caused by a blood clot (ischemic stroke). It is for patients who are already receiving standard clot-busting treatment within 8 hours of symptoms starting. The study will see if adding this drug helps improve recovery.
Linfen, ShanxiAges 18–80 - NCT07242768Recruiting
Long-term exercise follow-up for artery narrowing
This trial looks at the long-term effects of regular exercise for people with narrowed brain arteries. It follows participants from a previous study to see if exercise continues to help over three more years.
BeijingAges 40–80 - NCT07247838Recruiting
Gut bacteria changes in first-time stroke patients
This study looks at how gut bacteria change right after a first-time ischemic stroke. It aims to understand if these changes are linked to recovery or other health factors.
Nantong, JiangsuAges 18 years+ - NCT06342206Recruiting
TCM Assessment for Recent Ischemic Stroke
This study uses traditional Chinese medicine (TCM) diagnostic tools to evaluate patients who had an ischemic stroke within the last 10 days. It aims to understand the acute and chronic phases of stroke to help guide future treatments.
ChanghuaAges 20 years+ - NCT07235514Recruiting
Anesthesia management during clot removal for stroke
This trial compares different types of anesthesia given during mechanical thrombectomy (clot removal) for people who have a severe ischemic stroke from a large artery blockage. Researchers want to see which anesthesia approach leads to better recovery.
AngersAges 18 years+ - NCT07232498Recruiting
Early ultrasound-guided movement after a stroke
This trial tests if starting supervised mobility early (within 48 hours) using Doppler ultrasound to guide care can help recovery in adults who just had a stroke caused by a clot. It may help you avoid complications and regain function sooner.
RijekaAges 18 years+ - NCT04412187Recruiting
Study of inflammation after a new stroke
This study looks at inflammation-related changes soon after an acute ischemic stroke (a type caused by a blocked blood vessel). It may help researchers understand what factors drive recovery and how they could be targeted in the future.
Munich, GermanyAges 50 years+ - NCT05199194RecruitingPhase 3
Clot-busting before or during procedure for acute stroke
This study compares two treatment approaches for a stroke caused by a blocked brain artery: doing a procedure to remove the clot alone versus giving an IV clot-busting medicine first (tenecteplase). It aims to see which approach works better and is safest for improving recovery.
Porto Alegre, Rio Grande do SulAges 18–85 - NCT07205328RecruitingPhase 2
Testing MT200605 for acute ischemic stroke
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
Beijing, Beijing MunicipalityAges 18–80 - NCT06863571RecruitingPhase 3
Early medication combo to reduce swelling after stroke
This trial tests a combination of medicines given early after a large ischemic stroke to reduce brain swelling. It may help people who have had a stroke in the middle cerebral artery within the last 3 days and have a large area of brain damage.
Hangzhou, ZhejiangAges 18 years+ - NCT07201688RecruitingPhase 3
Extending the window for stroke clot-busting drug
This trial tests a clot-dissolving medication called rhTNK-tPA for people who had a stroke 4.5 to 24 hours ago. It aims to help those with certain types of blockages in the brain who are still having moderate to severe symptoms.
Puyang, HenanAges 18 years+
Hear when a new Ischemic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ischemic?
- Yes. Clin2 currently lists 814 recruiting ischemic studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ischemic trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ischemic trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.